These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2062717)

  • 1. Clinical diagnosis and course of Alzheimer's disease.
    Morris JC; Rubin EH
    Psychiatr Clin North Am; 1991 Jun; 14(2):223-36. PubMed ID: 2062717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
    Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
    Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
    Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consortium to establish a registry for Alzheimer's disease: development, database structure, and selected findings.
    Fillenbaum GG; Beekly D; Edland SD; Hughes JP; Heyman A; van Belle G
    Top Health Inf Manage; 1997 Aug; 18(1):47-58. PubMed ID: 10173753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease.
    Morris JC; Mohs RC; Rogers H; Fillenbaum G; Heyman A
    Psychopharmacol Bull; 1988; 24(4):641-52. PubMed ID: 3249766
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor structure of the CERAD neuropsychological battery.
    Strauss ME; Fritsch T
    J Int Neuropsychol Soc; 2004 Jul; 10(4):559-65. PubMed ID: 15327734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Italian version of Consortium to Establish a Registry of Alzheimer's Disease (CERAD).
    Lucca U; Tettamanti M; Quadri P
    Alzheimers Dement; 2008 Jul; 4(4):310. PubMed ID: 18631984
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral outcomes in clinical trials for Alzheimer disease.
    Ferris SH; Mackell JA
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 4():S10-5. PubMed ID: 9339267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A proposal for diagnostic and clinical assessment criteria for Alzheimer's disease].
    Shoji M; Kuwano R; Asada T; Imagawa M; Higuchi S; Urakami K; Arai H; Ihara Y; ;
    Rinsho Shinkeigaku; 2005 Feb; 45(2):128-37. PubMed ID: 15782613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease.
    Berres M; Monsch AU; Bernasconi F; Thalmann B; Stähelin HB
    Stud Health Technol Inform; 2000; 77():195-9. PubMed ID: 11187541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of Alzheimer's disease].
    Delacourte A
    Ann Biol Clin (Paris); 1998; 56(2):133-42. PubMed ID: 9754238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease.
    Künig G; Jäger M; Stief V; Kaldune A; Urbaniok F; Endrass J
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):911-6. PubMed ID: 16927401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early detection of cognitive changes in memory diseases: new cut-off scores for the Finnish version of CERAD neuropsychological battery].
    Hänninen T; Pulliainen V; Sotaniemi M; Hokkanen L; Salo J; Hietanen M; Pirttilä T; Pöyhönen M; Juva K; Remes A; Erkinjuntti T
    Duodecim; 2010; 126(17):2013-21. PubMed ID: 21053518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
    Small BJ; Gagnon E; Robinson B
    Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.
    Lambon Ralph MA; Patterson K; Graham N; Dawson K; Hodges JR
    Brain; 2003 Nov; 126(Pt 11):2350-62. PubMed ID: 12876147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia and Alzheimer's disease. Indications, diagnosis, and treatment.
    Golden R
    Minn Med; 1995 Jan; 78(1):25-9. PubMed ID: 7877576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.